AptarGroup, Inc.
NYSE:ATRMedical - Instruments & Supplies
+$0.66 today
- Market cap
- $8.98B
- Beta
- 0.40
- P/E (TTM)
- 20.0
- EPS (TTM)
- $6.04
- Dividend yield
- 1.57%
Volume 0.34M
Average 0.51M
ATR Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
AptarGroup, Inc.NYSE: ATR
Net Debt · Q2 FY2026 · quarter ended Jun 2026
Net debt rises 26.9% from a year ago
Net debt stood at $1.24B at the end of Q2 FY2026, up 26.9% from a year earlier and up 4.2% from the prior quarter. Over 3 fiscal years it compounded at +1.5% a year.
Context
- Net debt amounted to 24.1% of total assets at the end of Q2 FY2026, up 4.1 pp from a year earlier.
- Net debt increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net debt keeps rising in the next quarterly balance sheet after a +26.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- 1.13B USD
- Year-over-year change
- +32.4%
- 4-year CAGR
- +0.1%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.13B | +32.4% |
| FY2024 | 2024-12-31 | 852.22M | -11.3% |
| FY2023 | 2023-12-31 | 961.03M | -11.0% |
| FY2022 | 2022-12-31 | 1.08B | -3.7% |
| FY2021 | 2021-12-31 | 1.12B | — |
Net Debt vs competitors
How ATR compares with its peers on the latest reported figures
- Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +26.9% is the 2nd highest of 7, against a peer median of -3.4%.
- Net debt amounts to 24.1% of total assets for ATR, versus a peer median of 37.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $13.97B USD | -1.5% | +28.9% | 37.6% | |
| Jun 2026 | $4.48B USD | -5.3% | +5.0% | 46.7% | |
| Sep 2026 | $4.37B USD | -15.2% | +8.5% | 43.1% | |
| Jun 2026 | $1.24B USD | +26.9% | +1.5% | 24.1% | |
| Jun 2026 | €364.35M EUR | +13.6% | — | 13.9% | |
| Jun 2026 | -$123.7M USD | +40.1% | — | 3.0% | |
| Mar 2026 | -$870.33M USD | -292.9% | +12.7% | 37.9% | |
| Peer median (excluding ATR) | — | -3.4% | +10.6% | 37.8% | |
Competitors are the stored peer set for ATR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 122.93M | 141.73M | 223.64M | 223.84M | 402.42M |
| Short-term Investments | 740K | 0 | 0 | 2.34M | 7.11M |
| Net Receivables | 671.35M | 676.99M | 677.82M | 658.06M | 803.83M |
| Inventory | 441.46M | 486.81M | 513.05M | 461.81M | 537.85M |
| Other Current Assets | 0 | 124.77M | 134.76M | 13.64M | 142.35M |
| Total Current Assets | 1.36B | 1.43B | 1.55B | 1.48B | 1.89B |
| Property, Plant & Equipment (Net) | 1.34B | 1.4B | 1.54B | 1.51B | 1.74B |
| Goodwill | 974.16M | 945.63M | 963.42M | 936.26M | 1.08B |
| Intangible Assets | 362.34M | 315.74M | 283.21M | 254.77M | 255.34M |
| Long-term Investments | 59.49M | 52.31M | 49.2M | 146.27M | 131.03M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 48.84M | 57.14M | 69.64M | 105.24M | 152.71M |
| Total Non-current Assets | 2.78B | 2.77B | 2.9B | 2.95B | 3.36B |
| Total Assets | 4.14B | 4.2B | 4.45B | 4.43B | 5.25B |
| Account Payables | 285.26M | 320.28M | 328.57M | 295.97M | 340.56M |
| Short-term Debt | 285.88M | 122.79M | 458.22M | 338.29M | 343.53M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 86.95M | 80.24M | 60.51M | 64.43M | 74.83M |
| Other Current Liabilities | 195.31M | 206.33M | 222.01M | 211.44M | 232.6M |
| Total Current Liabilities | 982.49M | 917.18M | 1.25B | 1.07B | 1.17B |
| Long-term Debt | 907.02M | 1.05B | 681.19M | 688.07M | 1.14B |
| Deferred Tax Liabilities | 27.55M | 20.56M | 19.02M | 14.26M | 19.65M |
| Deferred Revenue (Non-current) | 21.91M | 25.36M | 37.76M | 0 | 0 |
| Other Non-current Liabilities | 169.79M | 76.61M | 96.06M | 126.03M | 167.03M |
| Total Non-current Liabilities | 1.17B | 1.22B | 879.28M | 878.07M | 1.37B |
| Total Liabilities | 2.16B | 2.14B | 2.13B | 1.95B | 2.54B |
| Common Stock | 704K | 709K | 717K | 725K | 728K |
| Retained Earnings | 1.79B | 1.93B | 2.11B | 2.37B | 2.64B |
| Accumulated OCI | (316.04M) | (341.37M) | (308.73M) | (429.48M) | (186.38M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 15.19M | 14.27M | 14.47M | 14.04M | 44.13M |
| Total Equity | 1.98B | 2.07B | 2.32B | 2.49B | 2.71B |
| Total Debt | 1.24B | 1.22B | 1.18B | 1.08B | 1.53B |
| Net Debt | 1.12B | 1.08B | 961.03M | 852.22M | 1.13B |
AptarGroup, Inc.
NYSE:ATR
Intrinsic Alpha fair value
Locked
Current Price
$141.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.